Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
The 2022 Annual Shareholders’ Meeting passes release the prohibition on directors from participation in competition businesses.
2022-06-21
The 2022 Annual Shareholders’ Meeting approved the Company’s list of newly elected directors (including independent directors).
2022-06-21
The important resolutions of the 2022 Annual Shareholders’ Meeting.
2022-06-21
Announcement on the expiry of members of the 4th term Remuneration Committee.
2022-06-17
The Board of Directors approved Q1 2022 consolidated financial statements.
2022-05-06
Change to the spokesperson and acting spokesperson of the company.
2022-05-06
The Board of Directors approved the convening of the 2022 Annual Shareholders’ Meeting.(additional matters for discussion)
2022-05-06
The Company is invited to attend an institutional investor conference hosted by President Securities on April 28, 2022.
2022-04-27
The Board of Directors approved dividend distribution
2022-03-11
The Board of Directors approved 2021 consolidated financial statements.
2022-03-11
